首页 › 基金 › RICE HALL JAMES & ASSOCIATES, LLC › NBIX
RICE HALL JAMES & ASSOCIATES, LLC 对 NBIX 的持仓历史
NEUROCRINE BIOSCIENCES INC · 医疗保健
RICE HALL JAMES & ASSOCIATES, LLC 在 Q3 2026 的 13F 申报中披露持有 NBIX(NEUROCRINE BIOSCIENCES INC)97,563 股,市值约 US$13.8M,约占其申报组合的 0.73%,在其申报持仓中市值排名第 43 位。 RICE HALL JAMES & ASSOCIATES, LLC 最近 13 个申报季度中有 13 个季度披露了 NBIX 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
RICE HALL JAMES & ASSOCIATES, LLC 对 NBIX 的持仓演变
RICE HALL JAMES & ASSOCIATES, LLC 于 Q3 2023 首次披露 NBIX 持仓:132,213 股(约 US$14.9M)。 该持仓在 Q1 2024 达到峰值 126,421 股,市值约 US$17.4M。 在 13 次申报中,RICE HALL JAMES & ASSOCIATES, LLC 1 次增持、9 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 97,563 股、市值约 US$13.8M,环比减持 -2,632 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 132.21K | $14.87M | 新进 |
| Q4 2023 | 131.62K | $17.34M | 持有 |
| Q1 2024 | 126.42K | $17.44M | 减持 |
| Q2 2024 | 118.11K | $16.26M | 减持 |
| Q3 2024 | 117.42K | $13.53M | 减持 |
| Q4 2024 | 110.63K | $15.10M | 减持 |
| Q1 2025 | 109.67K | $12.13M | 减持 |
| Q2 2025 | 108.38K | $13.62M | 减持 |
| Q3 2025 | 99.47K | $13.96M | 减持 |
| Q4 2025 | 98.02K | $13.90M | 减持 |
| Q1 2026 | 99.99K | $13.17M | 增持 |
| Q2 2026 | 100.19K | $16.89M | 持有 |
| Q3 2026 | 97.56K | $13.84M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NBIX 与 13F 数据
NBIX(NEUROCRINE BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 NBIX,申报仓位最大的包括:文艺复兴科技 (US$326.3M), Vestal Point Capital, LP (US$316.8M), RTW INVESTMENTS, LP (US$133.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NBIX 的基金
- 文艺复兴科技 2.30M 股 · $326.33M · Q3 2026
- Vestal Point Capital, LP 1.88M 股 · $316.85M · Q2 2026
- RTW INVESTMENTS, LP 942.68K 股 · $133.71M · Q3 2026
更多关于 RICE HALL JAMES & ASSOCIATES, LLC
常见问题
How long has RICE HALL JAMES & ASSOCIATES, LLC held NBIX?
RICE HALL JAMES & ASSOCIATES, LLC has disclosed NBIX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RICE HALL JAMES & ASSOCIATES, LLC's current position in NBIX?
As of Q3 2026, RICE HALL JAMES & ASSOCIATES, LLC holds 97.56K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $13.84M, representing 0.73% of its reported portfolio and ranking #43.
Has RICE HALL JAMES & ASSOCIATES, LLC been buying or selling NBIX?
In the latest 13F filing (Q3 2026), RICE HALL JAMES & ASSOCIATES, LLC reduced its position in NBIX. The position peaked in Q1 2024 at 126.42K shares.
Which other funds hold NBIX?
Other major institutional holders of NBIX include 文艺复兴科技, Vestal Point Capital, LP, RTW INVESTMENTS, LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.